Published in Am J Respir Crit Care Med on June 15, 2008
Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2007) 6.71
High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med (2005) 7.20
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet (2009) 3.21
IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res (2006) 2.66
Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. Am J Respir Crit Care Med (2008) 2.65
Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. Am J Respir Crit Care Med (2011) 2.62
Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2011) 2.54
Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am J Respir Crit Care Med (2010) 2.40
Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 2.26
The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med (2014) 2.18
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
The impact of traffic air pollution on bronchiolitis obliterans syndrome and mortality after lung transplantation. Thorax (2011) 1.62
Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med (2006) 1.54
Role of activin-A in cigarette smoke-induced inflammation and COPD. Eur Respir J (2013) 1.52
Effects of long-acting bronchodilators and placebo on histamine-induced asthma symptoms and mild bronchusobstruction. Respir Med (2005) 1.42
Preemptive therapy with steroids but not macrolides improves gas exchange in caustic-injured donor lungs. J Surg Res (2011) 1.40
Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: donor-related risk factors and markers. J Heart Lung Transplant (2005) 1.38
Lung function in idiopathic pulmonary fibrosis--extended analyses of the IFIGENIA trial. Respir Res (2009) 1.34
Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest (2003) 1.27
Involvement of p38 MAPK, JNK, p42/p44 ERK and NF-kappaB in IL-1beta-induced chemokine release in human airway smooth muscle cells. Respir Med (2003) 1.14
Quality of life in patients with Cystic Fibrosis: association with anxiety and depression. J Cyst Fibros (2008) 1.14
Nocturnal weakly acidic reflux promotes aspiration of bile acids in lung transplant recipients. J Heart Lung Transplant (2009) 1.11
Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients. Respir Res (2010) 1.07
The clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med (2013) 1.07
Survival determinants in lung transplant patients with chronic allograft dysfunction. Transplantation (2011) 1.05
Obliterative bronchiolitis following lung transplantation: from old to new concepts? Transpl Int (2009) 1.05
Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation. Transplantation (2004) 1.04
The pathogenesis of pulmonary fibrosis: a moving target. Eur Respir J (2012) 1.03
Primary ciliary dyskinesia: critical evaluation of clinical symptoms and diagnosis in patients with normal and abnormal ultrastructure. Orphanet J Rare Dis (2014) 1.03
Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders. Am J Respir Crit Care Med (2010) 1.01
Selective accumulation of langerhans-type dendritic cells in small airways of patients with COPD. Respir Res (2010) 1.01
Obese individuals with asthma preferentially have a high IL-5/IL-17A/IL-25 sputum inflammatory pattern. Am J Respir Crit Care Med (2014) 1.00
Repeated invasive lung function measurements in intubated mice: an approach for longitudinal lung research. Lab Anim (2011) 1.00
Methotrexate vs azathioprine in second-line therapy of sarcoidosis. Chest (2013) 1.00
Interleukin-17 stimulates release of interleukin-8 by human airway smooth muscle cells in vitro: a potential role for interleukin-17 and airway smooth muscle cells in bronchiolitis obliterans syndrome. J Heart Lung Transplant (2003) 0.97
Genomic copy number determines functional expression of {beta}-defensin 2 in airway epithelial cells and associates with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 0.97
Lung donor selection and management. Proc Am Thorac Soc (2009) 0.97
Airway colonization and gastric aspiration after lung transplantation: do birds of a feather flock together? J Heart Lung Transplant (2008) 0.97
Risk factors for airway complications within the first year after lung transplantation. Eur J Cardiothorac Surg (2007) 0.96
Interleukin-17--induced interleukin-8 release in human airway smooth muscle cells: role for mitogen-activated kinases and nuclear factor-kappaB. J Heart Lung Transplant (2005) 0.96
Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer? J Heart Lung Transplant (2010) 0.95
Multiplex protein profiling of bronchoalveolar lavage in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis. Ann Thorac Med (2013) 0.94
Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infection. Antimicrob Agents Chemother (2009) 0.92
A cohort description and analysis of the effect of gabapentin on idiopathic cough. Cough (2012) 0.90
The site and nature of airway obstruction after lung transplantation. Am J Respir Crit Care Med (2014) 0.89
Fatal Scopulariopsis infection in a lung transplant recipient: a case report. J Heart Lung Transplant (2005) 0.89
Medium-term outcome after lung transplantation is comparable between brain-dead and cardiac-dead donors. J Heart Lung Transplant (2011) 0.89
The number of lung transplants can be safely doubled using extended criteria donors; a single-center review. Transpl Int (2010) 0.89
Clinical use of biomarkers of survival in pulmonary fibrosis. Respir Res (2010) 0.89
Impact of air pollution on cystic fibrosis pulmonary exacerbations: a case-crossover analysis. Chest (2013) 0.89
N-acetylcysteine inhibits interleukin-17-induced interleukin-8 production from human airway smooth muscle cells: a possible role for anti-oxidative treatment in chronic lung rejection? J Heart Lung Transplant (2004) 0.87
Health related quality of life in cystic fibrosis: To work or not to work? J Cyst Fibros (2009) 0.87
Azithromycin reduces airway inflammation in a murine model of lung ischaemia reperfusion injury. Transpl Int (2008) 0.87
Should we ventilate or cool the pulmonary graft inside the non-heart-beating donor? J Heart Lung Transplant (2003) 0.87
Mechanisms of increased gastroesophageal reflux in patients with cystic fibrosis. Am J Gastroenterol (2012) 0.86
Primary endpoints in phase 3 clinical trials in idiopathic pulmonary fibrosis: one step at a time. Am J Respir Crit Care Med (2013) 0.86
Bronchoalveolar lavage neutrophilia in acute lung allograft rejection and lymphocytic bronchiolitis. J Heart Lung Transplant (2010) 0.86
Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS). Semin Respir Crit Care Med (2013) 0.86
Retrograde flush following topical cooling is superior to preserve the non-heart-beating donor lung. Eur J Cardiothorac Surg (2007) 0.86
Effects of high altitude and cold air exposure on airway inflammation in patients with asthma. Thorax (2013) 0.86
Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ? Transplantation (2013) 0.85
Involvement of interleukin-17 during lymphocytic bronchiolitis in lung transplant patients. J Heart Lung Transplant (2013) 0.85
Detection of Pseudomonas aeruginosa in sputum headspace through volatile organic compound analysis. Respir Res (2012) 0.85
End of life care for patients with cystic fibrosis. J Cyst Fibros (2011) 0.85
Elevated bronchoalveolar lavage eosinophilia correlates with poor outcome after lung transplantation. Transplantation (2014) 0.84
Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer. J Thorac Oncol (2015) 0.84
A porcine model of acute lung injury by instillation of gastric fluid. J Surg Res (2010) 0.84
How long can we preserve the pulmonary graft inside the nonheart-beating donor? Ann Thorac Surg (2004) 0.83
A decade of extended-criteria lung donors in a single center: was it justified? Transpl Int (2014) 0.83
Bronchial carcinoma after lung transplantation: a single-center experience. J Heart Lung Transplant (2012) 0.83
Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection. Transplantation (2012) 0.83
N-acetyl cysteine attenuates the inflammatory response in warm ischemic pig lungs. J Surg Res (2007) 0.81
De novo or persistent pseudomonal airway colonization after lung transplantation: importance for bronchiolitis obliterans syndrome? Transplantation (2008) 0.81
N-acetyl cysteine pre-treatment attenuates inflammatory changes in the warm ischemic murine lung. J Heart Lung Transplant (2007) 0.81
Azithromycin decreases MMP-9 expression in the airways of lung transplant recipients. Transpl Immunol (2011) 0.81
Non-heart-beating donors. Semin Thorac Cardiovasc Surg (2004) 0.81
Impact of traffic related air pollution indicators on non-cystic fibrosis bronchiectasis mortality: a cohort analysis. Respir Res (2014) 0.80
Nebulized N-acetyl cysteine protects the pulmonary graft inside the non-heart-beating donor. J Heart Lung Transplant (2005) 0.80